BRIEF-Lucy Scientific Discovery Terminated Amalgamation Agreement With Bluesky Biologicals on March 5

Reuters03-13

March 12 (Reuters) - Lucy Scientific Discovery Inc

* LUCY SCIENTIFIC DISCOVERY INC- ON MARCH 5, CO TERMINATED AMALGAMATION AGREEMENT BETWEEN CO AND BLUESKY BIOLOGICALS

* LUCY SCIENTIFIC DISCOVERY INC- TERMINATED AGREEMENT ON BASIS OF FAILURE OF BLUESKY TO TIMELY PROVIDE AUDITED FINANCIAL STATEMENTS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2419952105?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-13 05:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2419952105","market":"us","top_or_hot":-1,"title":"BRIEF-Lucy Scientific Discovery Terminated Amalgamation Agreement With Bluesky Biologicals on March 5","media":"Reuters","content":"<html><body><p>March 12 (Reuters) - Lucy Scientific Discovery Inc</p><p> :</p><p>   * LUCY SCIENTIFIC DISCOVERY INC-  ON MARCH 5, CO  TERMINATED AMALGAMATION AGREEMENT  BETWEEN CO AND BLUESKY BIOLOGICALS</p><p>   * LUCY SCIENTIFIC DISCOVERY INC- TERMINATED AGREEMENT ON BASIS OF FAILURE OF BLUESKY TO TIMELY PROVIDE AUDITED FINANCIAL STATEMENTS</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Lucy Scientific Discovery Terminated Amalgamation Agreement With Bluesky Biologicals on March 5</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Lucy Scientific Discovery Terminated Amalgamation Agreement With Bluesky Biologicals on March 5\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-13 05:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 12 (Reuters) - Lucy Scientific Discovery Inc :   * LUCY SCIENTIFIC DISCOVERY INC-  ON MARCH 5, CO  TERMINATED AMALGAMATION AGREEMENT  BETWEEN CO AND BLUESKY BIOLOGICALS   * LUCY SCIENTIFIC ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2419952105","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2419952105","pubTimestamp":1710277525,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 12  - Lucy Scientific Discovery Inc :   * LUCY SCIENTIFIC DISCOVERY INC-  ON MARCH 5, CO  TERMINATED AMALGAMATION AGREEMENT  BETWEEN CO AND BLUESKY BIOLOGICALS   * LUCY SCIENTIFIC DISCOVERY INC- TERMINATED AGREEMENT ON BASIS OF FAILURE OF BLUESKY TO TIMELY PROVIDE AUDITED FINANCIAL STATEMENTSSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1548497426.USD":"安联环球人工智能AT Acc","ON":"安森美半导体","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LSDI":"Lucy Scientific Discovery, Inc.","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4585":"ETF&股票定投概念","BK4512":"苹果概念","BK4141":"半导体产品","BK4007":"制药","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC"},"translate_title":"3月5日，露西科学发现公司终止了与蓝天生物制品公司的合并协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LSDI":0.9,"ON":0.69},"content_text":"March 12 (Reuters) - Lucy Scientific Discovery Inc :   * LUCY SCIENTIFIC DISCOVERY INC-  ON MARCH 5, CO  TERMINATED AMALGAMATION AGREEMENT  BETWEEN CO AND BLUESKY BIOLOGICALS   * LUCY SCIENTIFIC DISCOVERY INC- TERMINATED AGREEMENT ON BASIS OF FAILURE OF BLUESKY TO TIMELY PROVIDE AUDITED FINANCIAL STATEMENTSSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419952105"}